This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The University of Manchester. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Mohammed Jaffar: Innovator in Drug Targeting Technology
Introduction
Mohammed Jaffar is a notable inventor based in Withington, GB. He has made significant contributions to the field of drug targeting, particularly through his innovative methods that enhance the delivery of therapeutic agents to specific areas within the body.
Latest Patents
Jaffar holds a patent for a groundbreaking invention related to drug targeting. This invention provides a method for targeting a drug to areas of hypoxic and/or ischemic tissue within the body. The desired drug species is linked to a non-cytotoxic bioreductive carrier. Additionally, the invention includes novel bioreductive conjugates that comprise a non-cytotoxic bioreductive moiety linked to at least one therapeutic agent. These compounds are particularly suitable for treating various conditions, including rheumatoid arthritis, diabetes, atherosclerosis, stroke, sepsis, Alzheimer's disease, cancer, kidney disease, and more.
Career Highlights
Throughout his career, Mohammed Jaffar has worked with esteemed institutions such as the University of Manchester and University College Cardiff Consultants Limited. His work has focused on developing innovative solutions that address critical health issues through targeted drug delivery.
Collaborations
Jaffar has collaborated with notable colleagues, including David Blake and Declan Naughton. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Mohammed Jaffar's contributions to drug targeting technology exemplify the impact of innovative thinking in the medical field. His work continues to pave the way for advancements in treatment options for various diseases.